Drug Data and Databases
August 3, 2026
7 minutes

IFA (Informationsstelle für Arzneispezialitäten)

IFA stands for Informationsstelle für Arzneispezialitäten, a clearing house in Frankfurt am Main jointly owned by German pharmacy, wholesale and industry associations. Founded in 1987, it assigns the Pharmazentralnummer (PZN) and the Pharmacy Product Number (PPN), and publishes economic, legal and logistical data on pharmacy goods twice a month.

Table of contents
    TL;DR
    • IFA stands for Informationsstelle für Arzneispezialitäten, founded 1987, based in Frankfurt am Main.
    • It is owned by three associations: ABDA (pharmacies), BPI (industry) and PHAGRO (wholesale). The BAH sits on the board but is not a shareholder.
    • IFA assigns the PZN (Germany, eight digits), the PPN (international, ISO/IEC issuing agency) and UDI-DIs under EU 2017/745 and 2017/746.
    • Its information services are published on the 1st and 15th of each month, which sets the rhythm of German price and distribution status changes.
    • IFA is the source layer. Database providers are the product layer that licenses and processes it. The identifier comes from IFA either way.
    • The German and Austrian PZN are different numbers and are not interchangeable. Cross border matching needs PPN or GTIN.

    IFA stands for Informationsstelle für Arzneispezialitäten. The IFA GmbH, based in Frankfurt am Main, is the joint clearing house of German pharmacies, pharmaceutical wholesalers and the pharmaceutical industry, and it assigns the Pharmazentralnummer (PZN) that identifies every product sold through a German pharmacy.

    Almost every number on a German medicine package traces back to this one organisation, yet IFA itself is rarely described accurately. It is not a database vendor, not a price list, and not a regulator. It is infrastructure: a neutral body that collects what manufacturers report and hands identifiers back to the market. Understanding that distinction decides who you actually need a contract with, which is why the term causes so much confusion in data procurement conversations.

    Who owns IFA, and why does the ownership matter?

    IFA was founded in 1987 and is held by three associations, each representing one side of the German pharmacy market:

    ShareholderRepresentsFull name
    ABDAPharmaciesBundesvereinigung Deutscher Apothekerverbände
    BPIPharmaceutical industryBundesverband der Pharmazeutischen Industrie
    PHAGROPharmaceutical wholesaleBundesverband des Pharmazeutischen Großhandels

    Representatives of those three, together with the BAH, Pro Generika and the vfa, sit on the administrative board. A common error is to call the BAH a shareholder: it sits on the board but does not hold the company. André Maske has been managing director since 2024.

    That ownership structure is the whole point. Manufacturers, wholesalers and pharmacies have directly opposing commercial interests but depend on the same article data to trade with each other at all. IFA is the neutral ground where that shared data is maintained, which is why no single market side controls it.

    What does IFA actually assign?

    IFA collects economic, legal and logistical data on medicines, medical devices and other goods available in German pharmacies, and it issues three identifier types.

    IdentifierWhat it isScopeLegal or standards basis
    PZNPharmazentralnummer, eight digits including a check digit, the unique key for a product and pack sizeGermanyGerman market standard, used in pharmacy billing and wholesale ordering
    PPNPharmacy Product Number, which embeds the PZN in an internationally unambiguous formInternationalIFA acts as an issuing agency under ISO/IEC standards
    UDI-DIUnique Device Identification for medical devicesEUIFA is an issuing entity under EU Regulations 2017/745 (MDR) and 2017/746 (IVDR)

    The PZN is the one most people mean when they say IFA. It is worth being precise that a PZN identifies a specific pack of a specific product from a specific supplier, not a substance and not a brand. Two pack sizes of the same medicine carry two different PZNs, which is exactly why the number works as a primary key and exactly why substance-level questions cannot be answered with a PZN alone.

    How do products get into the IFA data, and on what rhythm?

    The flow runs in one direction, and each step is a place where data can go stale:

    1. The pharmaceutical company reports its article and price data to IFA, within the deadlines of the IFA editorial calendar.
    2. IFA assigns the PZN and maintains the record as the neutral clearing house.
    3. IFA publishes its information services to licensed data recipients.
    4. Those recipients process the data into the drug databases, article master data and pricing products that professionals actually use.
    5. Those products feed pharmacy software, wholesaler systems, hospital ERP and web shops.

    The critical operational fact: the IFA information services are published on the 1st and 15th of each month. This is why German price changes and distribution status changes cluster on those two dates instead of arriving continuously. Any system consuming this data has to be built around a twice monthly rhythm, and any pricing analysis that ignores it will misread the effective date of a change.

    How does IFA differ from ABDATA, AVOXA and IFAP?

    This is the distinction that gets blurred most often when teams compare data offers, and getting it wrong leads to negotiating with the wrong party.

    LayerWhoRoleWhat you get
    Source layerIFA GmbHAssigns identifiers, collects reported article data, publishes information servicesThe raw information service, in its original format and twice monthly rhythm
    Product layerData recipients and database providersLicense the information services and process them into usable productsLinked, enriched, searchable data with clinical and regulatory context

    So the question "should we buy from IFA or from a database provider" is usually the wrong question. The identifier comes from IFA either way. What differs is who processes it, how deeply it is linked to other data, and what your licence permits you to do with it. If you need the raw information service in its original delivery format, that is a licence you take at the source. If you need the data linked to clinical, regulatory and availability context and queryable, that is the product layer.

    Do Austria and Switzerland have an equivalent to IFA?

    Both have an equivalent function, but neither has an equivalent organisation, and the identifiers are not interchangeable. This trips up anyone extending a German data model across DACH.

    CountryBodyPrimary identifierNote
    GermanyIFA GmbH, Frankfurt am MainPZN, eight digitsOwned jointly by ABDA, BPI and PHAGRO
    AustriaARGE Pharma at the Fachverband der Chemischen Industrie Österreichs, with DATACAREAustrian PZN, six digits plus a check digitCombined with country code 90 and the ARGE Pharma identifier 8888 to form the NTIN
    SwitzerlandStiftung Refdata, ZugGTIN under Global Company Prefix 7680Refdata is the exclusive licensee of GCP 7680 for Swissmedic approved articles and also assigns GLNs

    The practical consequence is blunt: the German and Austrian PZN are different numbers and cannot be used interchangeably. A six digit Austrian PZN is not a truncated German one. Any cross border article matching has to run through an international identifier such as the PPN or GTIN, not through the national PZN.

    Where do professionals find IFA assigned identifiers on pharmazie.com?

    pharmazie.com is not an IFA data outlet. The identifiers reach the platform through the licensed ABDA article master data, where the PZN acts as the primary key across all connected databases and the neighbouring identifiers sit alongside it in the article base data.

    • Field: PZN as primary key; article base data including PPN, NTIN, GTIN and UDI-DI
    • Granularity: per PZN
    • Source: ABDA article master data (ABDATA Pharma-Daten-Service)
    • Updated: daily, with a source and date stamp on every detail page
    • Access: web app, REST API, data export

    One honest limitation: if what you need is the raw IFA information service itself, in its original delivery format and on its original twice monthly rhythm, that is a licence you take out at the source. No aggregator replaces it, and any provider claiming otherwise is describing a processed product, not the source feed.

    Sources

    Author Image
    Ursula Tschorn
    Ursula Tschorn is CEO of DACON Datenbank Consulting GmbH and has been building pharmaceutical information infrastructure since 1989. She writes on drug data standards, pricing regulation and market access in the DACH region.

    FAQ

    What does IFA stand for?
    Who assigns the PZN?
    Who owns IFA?
    What is the IFA-Informationsdienst?
    How do IFA, ABDATA and AVOXA differ?
    Do I need a raw data licence to work with IFA-based article data?

    Other terms

    Since 1989, over 1,000 customers have placed their trust in our data.

    The most comprehensive drug database for pharma professionals.